Streetbeat News

Analyst Ratings

ARRY

Array Technologies, Inc. (NASDAQ:ARRY) reported Q2 earnings of 47 cents per share, beating the analyst consensus estimate of 18 cents. The company also reported quarterly sales of $507.70 million, surpassing the analyst consensus estimate of $448.84 million. Array anticipates full-year 2023 revenue between $1.65 billion and $1.725 billion. JP Morgan analyst Mark Strouse maintained Array Technologies with an Overweight and raised the price target from $33 to $35.

Portfolio Pulse from Ryan Gustafson

August 09, 2023 | 6:52 pm

OLPX

Telsey Advisory Group analyst Dana Telsey downgraded Olaplex Holdings, Inc. (NASDAQ:OLPX) from Outperform to Market Perform, lowering the price target to $4 from $6. This follows disappointing Q2 results and a reduced FY23 outlook due to macro challenges in the consumer and professional segments. OLPX's revised guidance now looks for investments in sales and marketing to support stabilization in trends instead of growth.

Portfolio Pulse from Nabaparna Bhattacharya

August 09, 2023 | 6:51 pm

ROP

Roper Techs Inc.'s stock has increased by 3.25% over the past month and by 13.53% over the past year. The company's P/E ratio of 44.95 is lower than the Software industry's aggregate P/E ratio of 304.89, which could indicate that the stock is undervalued or that shareholders do not expect the stock to perform better in the future.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 6:45 pm

DOCS

Doximity, Inc. (NYSE:DOCS) shares fell over 20% after the company issued Q2 and full-year 2023 revenue guidance below estimates, despite beating Q1 earnings and sales estimates. The company also received several analyst downgrades and lowered price targets.

Portfolio Pulse from Ryan Gustafson

August 09, 2023 | 6:37 pm

ATSG

Susquehanna analyst Christopher N. Stathoulopoulos has reiterated a positive rating on Air Transport Services Group, Inc (ATSG), raising the price target to $26 from $18. The analyst views ATSG's decision to control capex amid an uncertain macroeconomic backdrop as prudent. ATSG's Q2 earnings beat estimates, and the FY23 adjusted EBITDA estimate has been slightly raised to $613 million. However, ATSG shares are trading lower by 1.19% to $22.43.

Portfolio Pulse from Nabaparna Bhattacharya

August 09, 2023 | 6:33 pm

EQNR

RBC Capital Market analyst Biraj Borkhataria has upgraded Equinor ASA (NYSE:EQNR) to Outperform from Sector Perform at a price target of NOK390.00. The analyst believes that the company has underperformed its peers YTD with European gas prices returning to the long-term trend from unusually high levels in 2022. Borkhataria expects a 2024 DPS of $3.68, 57% ahead of consensus and thinks investors are comfortable with 2023 distributions and focus is likely to shift to 2024. EQNR shares are trading up 5.1% at $32.44 on the last check Wednesday.

Portfolio Pulse from Lekha Gupta

August 09, 2023 | 6:18 pm

SE

A whale investor has taken a bullish stance on Sea (NYSE:SE), with 50% of investors opening trades with bullish expectations and 50% with bearish. The total amount for puts is $312,165 and for calls is $129,575. Whales have been targeting a price range from $53.0 to $70.0 for Sea over the last 3 months. The price of SE is down -1.77% at $56.31. UBS upgraded its action to Buy with a price target of $86.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 6:17 pm

CELH

LCID

PLUG

Goldman Sachs has highlighted several stocks as potential 'earnings-day short squeezes', including Lucid Group (LCID), Celsius Holdings (CELH), and Plug Power (PLUG). Lucid and Celsius have already reported, with Lucid's stock jumping 12.16% despite missing estimates, and Celsius' stock rising approximately 20% after strong quarterly results. Plug Power, which has missed bottom-line estimates for nine straight quarters, is set to report its Q2 results and could potentially experience a short squeeze due to its high short interest of 21.34%.

Portfolio Pulse from Adam Eckert

August 09, 2023 | 6:05 pm

INZY

Over the past 3 months, 4 analysts have published bullish opinions on Inozyme Pharma (NASDAQ:INZY) stock, with an average 12-month price target of $19.5, an increase of 2.63% from the previous average price target of $19.00.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 6:01 pm

JELD

In the last quarter, JELD-WEN Holding (NYSE:JELD) received mostly indifferent ratings from analysts, with one somewhat bearish rating. The average price target is $16.5, slightly above the current price of $16.1099. This target has increased by 17.86% over the past month.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 6:01 pm